BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 24789813)

  • 21. The aryl hydrocarbon receptor-interacting protein gene is rarely mutated in sporadic GH-secreting adenomas.
    Iwata T; Yamada S; Mizusawa N; Golam HM; Sano T; Yoshimoto K
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):499-502. PubMed ID: 17371465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas.
    Leontiou CA; Gueorguiev M; van der Spuy J; Quinton R; Lolli F; Hassan S; Chahal HS; Igreja SC; Jordan S; Rowe J; Stolbrink M; Christian HC; Wray J; Bishop-Bailey D; Berney DM; Wass JA; Popovic V; Ribeiro-Oliveira A; Gadelha MR; Monson JP; Akker SA; Davis JR; Clayton RN; Yoshimoto K; Iwata T; Matsuno A; Eguchi K; Musat M; Flanagan D; Peters G; Bolger GB; Chapple JP; Frohman LA; Grossman AB; Korbonits M
    J Clin Endocrinol Metab; 2008 Jun; 93(6):2390-401. PubMed ID: 18381572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The AIP (aryl hydrocarbon receptor-interacting protein) gene and its relation to the pathogenesis of pituitary adenomas.
    Lloyd C; Grossman A
    Endocrine; 2014 Aug; 46(3):387-96. PubMed ID: 24366639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AIP gene and familial isolated pituitary adenomas.
    Ozfirat Z; Korbonits M
    Mol Cell Endocrinol; 2010 Sep; 326(1-2):71-9. PubMed ID: 20457215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families.
    Igreja S; Chahal HS; King P; Bolger GB; Srirangalingam U; Guasti L; Chapple JP; Trivellin G; Gueorguiev M; Guegan K; Stals K; Khoo B; Kumar AV; Ellard S; Grossman AB; Korbonits M;
    Hum Mutat; 2010 Aug; 31(8):950-60. PubMed ID: 20506337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Large genomic deletions in AIP in pituitary adenoma predisposition.
    Georgitsi M; Heliövaara E; Paschke R; Kumar AV; Tischkowitz M; Vierimaa O; Salmela P; Sane T; De Menis E; Cannavò S; Gündogdu S; Lucassen A; Izatt L; Aylwin S; Bano G; Hodgson S; Koch CA; Karhu A; Aaltonen LA
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4146-51. PubMed ID: 18628514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Familial isolated pituitary adenoma: evidence for genetic heterogeneity.
    Toledo RA; Lourenço DM; Toledo SPA
    Front Horm Res; 2010; 38():77-86. PubMed ID: 20616498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Familial pituitary adenomas - who should be tested for AIP mutations?
    Korbonits M; Storr H; Kumar AV
    Clin Endocrinol (Oxf); 2012 Sep; 77(3):351-6. PubMed ID: 22612670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclin-dependent kinase inhibitor 1B (CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenoma kindreds.
    Tichomirowa MA; Lee M; Barlier A; Daly AF; Marinoni I; Jaffrain-Rea ML; Naves LA; Rodien P; Rohmer V; Faucz FR; Caron P; Estour B; Lecomte P; Borson-Chazot F; Penfornis A; Yaneva M; Guitelman M; Castermans E; Verhaege C; Wémeau JL; Tabarin A; Fajardo Montañana C; Delemer B; Kerlan V; Sadoul JL; Cortet Rudelli C; Archambeaud F; Zacharieva S; Theodoropoulou M; Brue T; Enjalbert A; Bours V; Pellegata NS; Beckers A
    Endocr Relat Cancer; 2012 Jun; 19(3):233-41. PubMed ID: 22291433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Germline mutation in the aryl hydrocarbon receptor interacting protein gene in familial somatotropinoma.
    Toledo RA; Lourenço DM; Liberman B; Cunha-Neto MB; Cavalcanti MG; Moyses CB; Toledo SP; Dahia PL
    J Clin Endocrinol Metab; 2007 May; 92(5):1934-7. PubMed ID: 17341560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular genetics of the aip gene in familial pituitary tumorigenesis.
    Tahir A; Chahal HS; Korbonits M
    Prog Brain Res; 2010; 182():229-53. PubMed ID: 20541668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aryl hydrocarbon receptor interacting protein gene (AIP) mutations are rare in patients with hormone secreting or non-secreting pituitary adenomas.
    Buchbinder S; Bierhaus A; Zorn M; Nawroth PP; Humpert P; Schilling T
    Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):625-8. PubMed ID: 18484068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update on the treatment of pituitary adenomas: familial and genetic considerations.
    Daly AF; Beckers A
    Acta Clin Belg; 2008; 63(6):418-24. PubMed ID: 19170361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations in the aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomas.
    Barlier A; Vanbellinghen JF; Daly AF; Silvy M; Jaffrain-Rea ML; Trouillas J; Tamagno G; Cazabat L; Bours V; Brue T; Enjalbert A; Beckers A
    J Clin Endocrinol Metab; 2007 May; 92(5):1952-5. PubMed ID: 17299063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Aryl hydrocarbon receptor interacting protein gene and familial isolated pituitary adenomas].
    Cai F; Zhang YD; Dai CX; Liu XH; Yang YK; Yao Y; Wang RZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Dec; 34(6):640-4. PubMed ID: 23286415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Familial isolated pituitary adenoma caused by a Aip gene mutation not described before in a family context.
    García-Arnés JA; González-Molero I; Oriola J; Mazuecos N; Luque R; Castaño J; Arraez MA
    Endocr Pathol; 2013 Dec; 24(4):234-8. PubMed ID: 24078436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel truncating AIP mutation, p.W279*, in a familial isolated pituitary adenoma (FIPA) kindred.
    Cansu GB; Taşkıran B; Trivellin G; Faucz FR; Stratakis CA
    Hormones (Athens); 2016 Jul; 15(3):441-444. PubMed ID: 27838609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications.
    Jaffrain-Rea ML; Angelini M; Gargano D; Tichomirowa MA; Daly AF; Vanbellinghen JF; D'Innocenzo E; Barlier A; Giangaspero F; Esposito V; Ventura L; Arcella A; Theodoropoulou M; Naves LA; Fajardo C; Zacharieva S; Rohmer V; Brue T; Gulino A; Cantore G; Alesse E; Beckers A
    Endocr Relat Cancer; 2009 Sep; 16(3):1029-43. PubMed ID: 19556287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of AIP variants in pituitary adenomas and concomitant thyroid carcinomas in the Netherlands: a nationwide pathology registry (PALGA) study.
    Coopmans EC; Muhammad A; Daly AF; de Herder WW; van Kemenade FJ; Beckers A; de Haan M; van der Lely AJ; Korpershoek E; Neggers SJCMM
    Endocrine; 2020 Jun; 68(3):640-649. PubMed ID: 32333269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical experience in the screening and management of a large kindred with familial isolated pituitary adenoma due to an aryl hydrocarbon receptor interacting protein (AIP) mutation.
    Williams F; Hunter S; Bradley L; Chahal HS; Storr HL; Akker SA; Kumar AV; Orme SM; Evanson J; Abid N; Morrison PJ; Korbonits M; Atkinson AB
    J Clin Endocrinol Metab; 2014 Apr; 99(4):1122-31. PubMed ID: 24423289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.